Martin Brenner
Chief Executive Officer at IBIO, INC.
Net worth: 37 048 $ as of 30/03/2024
Profile
Martin B.
Brenner's current job is Chief Executive & Scientific Officer at iBio, Inc. Formerly, Dr. Brenner worked as Senior Director & Head-BioScience at AstraZeneca PLC from 2012 to 2013.
He then served as Executive Director-Diabetes & NASH at Merck Research Laboratories Massachusetts LLC from 2013 to 2016.
Dr. Brenner was also the Head-Insulin Resistance Group at Pfizer Inc. Additionally, he held the position of Chief Scientific Officer at Recursion Pharmaceuticals, Inc. from 2017 to 2018.
From 2019 to 2020, Dr. Brenner worked as Chief Scientific Officer & Senior Vice President at Pfenex, Inc. He also served as VP & Head-Research & Early Development at Stoke Therapeutics, Inc. from 2016 to 2017.
Dr. Brenner obtained a doctorate degree from Ludwig-Maximilians-Universität München.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
IBIO, INC.
0.11% | 31/10/2023 | 9,125 ( 0.11% ) | 37 048 $ | 30/03/2024 |
Martin Brenner active positions
Companies | Position | Start |
---|---|---|
IBIO, INC. | Chief Executive Officer | 19/01/2023 |
Former positions of Martin Brenner
Companies | Position | End |
---|---|---|
PFENEX INC. | Chief Tech/Sci/R&D Officer | 30/09/2020 |
RECURSION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/12/2017 |
STOKE THERAPEUTICS, INC. | Corporate Officer/Principal | 31/12/2016 |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Director/Board Member | 31/12/2015 |
ASTRAZENECA PLC | Corporate Officer/Principal | 31/12/2012 |
Training of Martin Brenner
Ludwig-Maximilians-Universität München | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
PFIZER, INC. | Health Technology |
ASTRAZENECA PLC | Health Technology |
RECURSION PHARMACEUTICALS, INC. | Health Technology |
IBIO, INC. | Health Technology |
STOKE THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Pelican Inc
Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Martin Brenner